IRadimed

Winter Springs, United States Founded: 2004 • Age: 22 yrs
Developer of IV Infusion system and patient monitoring systems for the MRI setting
Annual revenue $73.2M Latest available
Total funding $1.5M 1 rounds
Employees 160 Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About IRadimed

IRadimed is a company based in Winter Springs (United States) founded in 2004. IRadimed has raised $1.5 million across 1 funding round. The company has 160 employees as of December 31, 2024. IRadimed offers products and services including 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories. IRadimed operates in a competitive market with competitors including 410 Medical, Hospira, Ivenix, Belmont Medical Technologies and Linear Health Sciences, among others.

  • Headquarter Winter Springs, United States
  • Employees 160 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Iradimed Corporation
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $73.24 M (USD)
    11.71
    as on Dec 31, 2024
  • Net Profit
    $19.23 M (USD)
    11.87
    as on Dec 31, 2024
  • EBITDA
    $22.78 M (USD)
    9.53
    as on Dec 31, 2024
  • Total Equity Funding
    $1.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.5 M (USD), Seed

    Apr 27, 2005

  • Investors
  • Employee Count
    160

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of IRadimed

IRadimed is a publicly listed company on the NASDAQ with ticker symbol IRMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: IRMD · Sector: Health technology · USA

Products & Services of IRadimed

IRadimed offers a comprehensive portfolio of products and services, including 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories.

Primary

Non-magnetic device for continuous vital sign tracking in MRI environments

Non-magnetic pump for safe medication delivery during MRI procedures

Ferrous metal detector to reduce false alarms in MRI settings

Accessories enhancing MRI patient care and workflow efficiency

People of IRadimed

Headcount 50-200
Employee Profiles 23
Employee Profiles
People
Ivan Cruz
Director Of Finance
People
Daniel Bennett
Vice President Of Regulatory Affairs And Quality Assurance
People
Rob Mayer
Territory Sales Manager
People
Randy Waddell
Vice President Of Worldwide Sales & Marketing

Unlock access to complete

Funding Insights of IRadimed

IRadimed has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.5 million completed in April 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $1.5M
  • First Round

    (27 Apr 2005)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2005 Amount Seed - IRadimed Valuation

investors

Investments & Acquisitions by IRadimed

Investments

Financial Statements - IRadimed

Iradimed Comparisons

+
Add Comparison
Available on Premium

Competitors of IRadimed

IRadimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 410 Medical, Hospira, Ivenix, Belmont Medical Technologies and Linear Health Sciences, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Rapid infusion systems are provided for critically ill patients.
domain founded_year HQ Location
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
domain founded_year HQ Location
Infusion management systems are developed with wireless web-based architecture.
domain founded_year HQ Location
Fluid management and critical care medical devices are developed.
domain founded_year HQ Location
IV breakaway valves are provided to prevent medical tubing dislodgement.

Latest news on Iradimed

Frequently Asked Questions about IRadimed

IRadimed was founded in 2004 and raised its 1st funding round 1 year after it was founded.

IRadimed is headquartered in Winter Springs, United States. It is registered at Winter Springs, Florida, United States.

IRadimed is a funded company, having raised a total of $1.5M across 1 funding round to date. The company's 1st funding round was a Seed of $1.5M, raised on Apr 27, 2005.

As of Dec 31, 2024, the latest employee count at IRadimed is 160.

Annual revenue of IRadimed is $73.24M as on Dec 31, 2024.

IRadimed was founded in 2004 and is headquartered in Winter Springs, United States. Medical devices for the MRI environment are developed and manufactured by the company, focusing on patient monitoring systems and IV infusion systems. FDA 510(k) clearance was obtained in 2005 for the Non-Magnetic MRidium Smart Infusion System, with additional clearance in 2009 for integration with Masimo SET SpO2 monitoring. Operations center on non-magnetic solutions for safe MRI use.

IRadimed's top competitors include 410 Medical, Belmont Medical Technologies and Hospira.

IRadimed offers 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories.

Yes, IRadimed is publicly traded on NASDAQ under the ticker symbol IRMD.

The ticker symbol of IRadimed is IRMD on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available